◆ 会议时间：2020年4月2-4日 虚拟会议：2020年10月2-3日
◆ 会议地点：德国 慕尼黑Munich
◆ 会议简介：
2020年第7届癌症免疫治疗大会-虚拟会议将于2020年10月2-3日举行，本次会议由WMA GmbH与ITOC协会、慕尼黑肿瘤中心(TZM)、癌症免疫治疗协会(SITC)、德国癌症协会(DKTK)以及慕尼黑综合癌症中心(CCCM)合作举办。该会议是欧洲领先的会议，为免疫肿瘤学领域的转化研究提供一个全球性的平台。ITOC系列会议是首屈一指的癌症免疫治疗教育、科学交流会议，旨在为所有从事免疫治疗的专业人士提供一个讨论早期临床药物研发，应对转化研究所面临的独特挑战的论坛；大会议题将侧重于最新的挑战和创新，特别强调联合治疗，免疫监测和生物标志物开发(未经本站许可，禁止复制摘录镜像本站任何内容-领域国际医学会议网)。
It aims at providing a forum for all professionals working in immunotherapy to discuss early clinical drug development and address the unique challenges of translational research.
The programme will focus on the latest challenges and innovations with a special emphasis on combination therapy, immuno-monitoring and biomarker development(lingyuint).
At this conference, we are in particular addressing preclinical and clinical scientists, clinical investigators, postdoctoral fellows involved in cancer research, regulatory scientists, healthcare professionals and the pharmaceutical industry.
重要日期/Important Dates
Abstract Submission Deadline: June 30, 2020
Deadline for Pre-registration: September 14, 2020
注册费/REGISTRATION FEES (IN EUR)
All fees include 20% Austrian VAT
Academia ： EUR 200,-
Junior Participant(1) ： EUR 100,-
Industry ：EUR 300,-
Press/Media Registration(2) ： no fee, but registration is mandatory
(1) The “Junior Participant” registration is available for Students under 30 years of age. Please provide a copy of a student ID at the moment of your registration either by fax to +43 1 405 13 83 918 or upload a jpeg, jpg, gif, bmp or png
(3) A Press ID confirming your status must be provided at the moment of your registration either by fax to +43 1 405 13 83 918 or upload a jpeg, jpg, gif, bmp or png
Payments should be made without charges to the beneficiary. Any bank charges will be claimed.
Clearly state the participant's name(s) and the invoice number on the bank transfer.
What is covered by the registration fee?
-
Admission to all scientific sessions (Live, On-Demand, e-Poster)
-
Abstract book and programme (both online)
-
Admission to the virtual company corner
◆ 参会对象：
临床医生、药物开发人员，肿瘤学家、企业代表，以及从事癌症免疫治疗研究的相关专业人士等等。
|
